SynthesisThe Cochrane database of systematic reviews2021

Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.

Alexandra McAleenan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.